RDEB: regeneration is not enough

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 61, Issue 12, 2008, Pages 1421-1422

  Burd, Andrew ^a  

^a JPRAS ^*  (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; TYPE VII COLLAGEN; UNCLASSIFIED DRUG;

CELL THERAPY; DERMOEPIDERMAL JUNCTION; DISEASE SEVERITY; DNA MODIFICATION; EDITORIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLAST; GENE MUTATION; HUMAN; KERATINOCYTE; NAIL DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING;

ANIMALS; DISEASE MODELS, ANIMAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLASTS; HUMANS; KERATINOCYTES; MICE; REGENERATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 55249120755     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2008.10.008     Document Type: Editorial

References (15)

1. Burgeson R.E., and Christiano A.M. The dermal-epidermal junction. Curr Opin Cell Biol 9 (1997) 651-658
2. Dang N., and Murrell D.F. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 17 (2008) 553-568
3. Woodley D.T., Hou Y., Martin S., et al. Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis. J Biol Chem 283 (2008) 17838-17845
4. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol 27 (2002) 616-623
5. Mavilio F., Pellegrini G., Ferrari S., et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12 (2006) 1397-1402
6. Falabella A.F., Valencia I.C., Eaglstein W.H., et al. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol 136 (2000) 1225-1230
7. Goto M., Sawamura D., Ito K., et al. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. J Invest Dermatol 126 (2006) 766-772
8. Chen M., and Woodley D.T. Fibroblasts as target cells for DEB gene therapy. J Invest Dermatol 126 (2006) 708-710
9. Wong T., Gammon L., Liu L., et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128 (2008) 2179-2189
10. Uitto J. Epidermolysis bullosa: prospects for cell-based therapies. J Invest Dermatol 128 (2008) 2140-2142
11. Marionnet C., Pierrard C., Vioux-Chagnoleau C., et al. Interactions between fibroblasts and keratinocytes in morphogenesis of dermal epidermal junction in a model of reconstructed skin. J Invest Dermatol 126 (2006) 971-979
12. Jiang Q.J., and Uitto J. Animal models of epidermolysis bullosa - targets for gene therapy. J Invest Dermatol 124 (2005) xi-xiii
13. Heinonen S., Mannikko M., Klement J.F., et al. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci 112 (1999) 3641-3648
14. Fritsch A., Loeckermann S., Kern J.S., et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118 (2008) 1669-1679
15. Burd A. Salamanders, lizards and ubiquitous stem cells. J Plast Reconstr Aesthet Surg 61 (2008) 121-123